Adverse Events Following Immunization Monitoring-Covid-19 Vaccines-Lebanon

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	151,777,679 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	27,390,281 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution	89,046,707 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	151,777,679 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 500IU	500IU	Injectable powder for solution+solvent	76,080,435 L.L
L01FD01	MABTIN 440	BioTech	Trastuzumab (r-DNA origin) - 440mg	440mg	Injectable powder for solution	70,042,700 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	226,619,295 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 1000IU	1000IU	Injectable powder for solution+solvent	143,279,414 L.L
L01FD01	OGIVRI	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	80,027,615 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 80mg/4ml	80mg/4ml	Injectable concentrated solution	11,127,864 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 2000IU	2000IU	Injectable powder for solution+solvent	286,711,575 L.L
L01FD01	TRASTUREL	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	52,047,114 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 162mg/0.9ml	162mg/0.9ml	Injectable solution	79,959,812 L.L
L01FD01	TRAZIMERA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for solution+solvent	75,295,202 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	25,485,937 L.L
L01FD01	ARYOTRUST	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	21,176,745 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	47,925,322 L.L
M03AX01	BOTOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100U	100U	Injectable powder for solution	18,625,995 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	36,062,671 L.L
L04AC10	COSENTYX	BioTech	Secukinumab - 150mg/ml	150mg/ml	Injectable solution	70,463,329 L.L
M03AX01	BOTOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100U	100U	Injectable powder for solution	18,625,995 L.L
L01FD01	TRAZIMERA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for solution	28,550,630 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	85,080,792 L.L
M03AX01	NEURONOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100units	100units	Injectable lyophilised powder for solution	13,011,437 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	105,957,406 L.L
L01FD01	KANJINTI	BioTech	Trastuzumab - 420mg	420mg	Injectable powder for concentrate for solution	79,305,881 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
M03AX01	XEOMIN	BioTech	Clostridium botulinum type A neurotoxin complex - 100 units LD50	100 units LD50	Injectable powder for solution	20,517,541 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	16,902,713 L.L
L01FD02	PERJETA 420MG	BioTech	Pertuzumab - 420mg/14ml	420mg/14ml	Injectable concentrate for solution	220,054,714 L.L